Abu Dhabi:The Abu Dhabi Public Health Centre (ADPHC) has entered into a Memorandum of Understanding (MoU) with Pfizer Gulf FZ LLC to collaborate on initiatives focused on disease prevention, scientific research, and the evaluation of emerging healthcare technologies.

According to Wam, the announcement of this partnership was made during the Abu Dhabi Future Health Summit (ADFHS) 2026. The collaboration aims to align scientific expertise with Abu Dhabi's public health priorities, facilitating evidence-based prevention and earlier detection of diseases.

The MoU was signed by Dr. Rashed Obaid Al Suwaidi, Director General of ADPHC, and Dr. Amr Seif, Gulf Cluster Lead at Pfizer, in the presence of Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi. The partnership will explore initiatives related to disease awareness and prevention, including screening and early diagnosis, with a focus on leveraging AI and digital solutions to enhance healthcare delivery and clinical decision-making.

Dr. Rashed Obaid Al Suwaidi emphasized the importance of understanding the health needs of the population and utilizing evidence to guide actions. He highlighted the potential of the collaboration with Pfizer to strengthen local research, exchange expertise, and assess how emerging technologies could support public health priorities.

Dr. Amr Seif remarked on the transformative potential of integrating science, data, and artificial intelligence into healthcare. He noted that the collaboration aims to explore innovative approaches to enhance prevention, generate local evidence, and support informed health decisions for better outcomes for patients and communities.